Travoprost Patent Expiration
Travoprost was first introduced by Alcon Pharmaceuticals Ltd
Travoprost Patents
Given below is the list of patents protecting Travoprost, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Idose Tr | US12201555 | Drug eluting ocular implant | Feb 14, 2031 | Glaukos |
| Idose Tr | US10206813 | Implants with controlled drug delivery features and methods of using same | Oct 17, 2030 | Glaukos |
| Idose Tr | US11426306 | Implants with controlled drug delivery features and methods of using same | Oct 17, 2030 | Glaukos |
| Idose Tr | US12201557 | Drug eluting ocular implant and method of treating an ocular disorder | Jun 18, 2030 | Glaukos |
| Travatan Z | US8268299 | Self preserved aqueous pharmaceutical compositions | Oct 13, 2029 | Sandoz |
| Izba | US8178582 | Pharmaceutical compositions having desirable bioavailability | Oct 10, 2029 | Novartis |
| Izba | US8722735 | Pharmaceutical compositions having desirable bioavailability | Oct 10, 2029 | Novartis |
| Izba | US8754123 | Pharmaceutical compositions having desirable bioavailability | May 19, 2029 | Novartis |
| Izba | US9144561 | Pharmaceutical compositions having desirable bioavailability | Mar 13, 2029 | Novartis |
| Travatan Z | US8323630 | Self-preserved aqueous pharmaceutical compositions | Sep 20, 2027 | Sandoz |
| Travatan Z | US8388941 | Self preserved aqueous pharmaceutical compositions | Sep 20, 2027 | Sandoz |
| Travatan | US5631287 | Storage-stable prostaglandin compositions |
Dec 22, 2014
(Expired) | Alcon Pharms Ltd |
| Travatan | US5849792 | Storage-stable prostaglandin compositions |
Dec 22, 2014
(Expired) | Alcon Pharms Ltd |
| Travatan | US6011062 | Storage-stable prostaglandin compositions |
Dec 22, 2014
(Expired) | Alcon Pharms Ltd |
| Travatan | US5889052 | Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension |
Dec 02, 2014
(Expired) | Alcon Pharms Ltd |
| Travatan Z | US5889052 | Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension |
Dec 02, 2014
(Expired) | Sandoz |
| Travatan | US5510383 | Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension |
Aug 03, 2013
(Expired) | Alcon Pharms Ltd |
| Travatan Z | US5510383 | Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension |
Aug 03, 2013
(Expired) | Sandoz |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Travoprost's patents.
Latest Legal Activities on Travoprost's Patents
Given below is the list recent legal activities going on the following patents of Travoprost.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 22 May, 2024 | US8323630(Litigated) |
| Payment of Maintenance Fee, 12th Year, Large Entity | 06 Mar, 2024 | US8268299(Litigated) |
| Payment of Maintenance Fee, 8th Year, Large Entity | 21 Aug, 2020 | US8388941 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 21 May, 2020 | US8323630(Litigated) |
| Payment of Maintenance Fee, 8th Year, Large Entity | 05 Mar, 2020 | US8268299(Litigated) |
| Review Certificate Mailed | 11 Jun, 2019 | US8268299(Litigated) |
| Review Certificate | 02 May, 2019 | US8268299(Litigated) |
| Termination or Final Written Decision | 20 Sep, 2018 | US8268299(Litigated) |
| Request for Trial Granted Critical
| 22 Sep, 2017 | US8268299(Litigated) |
| Petition Entered | 28 Mar, 2017 | US8268299(Litigated) |
Travoprost's Family Patents
